Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ocean Blue Innovation (OBI) is a Japanese venture studio and company builder focused on the intersection of marine biotechnology and the life sciences. Established in 2022 with backing from the University of Tokyo Innovation Platform (UTokyo IPC), the company identifies and develops high-potential academic research into commercial ventures. OBI specializes in the "Blue Economy," leveraging marine-derived bioactive compounds and synthetic biology to create novel therapeutics and healthcare solutions. The firm provides strategic management, seed funding, and operational support to bridge the gap between laboratory discovery and market-ready startups. By focusing on the untapped potential of oceanic resources, OBI aims to address global challenges in human health and environmental sustainability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ocean Blue Innovation.